LabCorp/Myriad Genetics
This article was originally published in The Gray Sheet
Executive Summary
Myriad predictive medicine products, including the BracAnalysis test for assessing a woman's risk of developing breast or ovarian cancer, will be distributed by LabCorp's 600-rep U.S. sales force in addition to Myriad's 85-person oncology sales force, under an exclusive marketing alliance announced Dec. 4...